DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper publication27-06-2022
27-06-2022
Dr Reddy's settles therapeutic drug patent litigation with Indivior, Aquestive Therapeutics
To get $72 million by March 31, 202424-06-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr. Reddy''s Laboratories announces the acquisition of an injectable product portfolio from Eton Pharma24-06-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation
Intimation - Settlement Agreement with respect to buprenorphine and naloxone sublingual film24-06-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of stock options under ESOPs23-06-2022
Dr. Reddy's growth strategy will require smooth execution
The emerging market business grew at a CAGR of about 16% in FY19-22 and there are plans to scale up this business22-06-2022
3 stocks to buy, accumulate with potential upside of up to 50%
Jefferies has a Buy rating on Dr Reddys shares with a target price of 5,036 apiece22-06-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor day presentation21-06-2022
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for AGM date and book closure20-06-2022